alexa Diabetes Mellitus, Insulin, Sulfonylurea and Advanced F
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Diabetes Mellitus, Insulin, Sulfonylurea and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

George Boon-Bee Goh1, Mangesh R Pagadala1, Jaividhya Dasarathy3, Aynur Unalp-Arida7, Ruth Sargent1, Carol Hawkins2, Achuthan Sourianarayanane1, Amer Khiyami5, Lisa Yerian4, Rish K Pai4, Srinivasan Dasarathy1,6 and Arthur J McCullough1,6*

1Departments of Gastroenterology at Cleveland Clinic, Johns Hopkins University, USA

2MetroHealth Medical Center, Johns Hopkins University, USA

3Department of Family Medicine at MetroHealth Medical Center, Johns Hopkins University, USA

4Departments of Pathology at Cleveland Clinic, Johns Hopkins University, USA

5MetroHealth Medical Center, Johns Hopkins University, USA

6Department of Pathobiology at Cleveland Clinic, Johns Hopkins University, USA

7Department of Public Health, Johns Hopkins University, USA

*Corresponding Author:
Arthur J McCullough
Department of Gastroenterology
Cleveland Clinic Foundation 9500 Euclid Avenue/A30
Cleveland, OH 44195, USA
Tel: 1-216-444-6521
Fax: 1-216-444-3889
E-mail: [email protected]

Received date: June 27, 2014; Accepted date: July 26, 2014; Published date: August 03, 2014

Citation: Goh GBB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, et al. (2014) Diabetes Mellitus, Insulin, Sulfonylurea and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease. J Diabetes Metab 5:410 doi: 10.4172/2155-6156.1000410

Copyright: © 2014 Goh GBB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background & aims: Diabetes mellitus is a risk factor for advanced fibrosis in non-alcoholic fatty liver disease. However, not all non-alcoholic fatty liver disease patients with diabetes develop advanced fibrosis. We hypothesised that prescription medications used by these patients influence the development of advanced fibrosis. We investigated the association of commonly used medications and advanced fibrosis in non-alcoholic fatty liver disease patients with diabetes.

Methods: Clinical information including demographics, medical history, medication history, biochemical and histologic variables were ascertained in 459 patients with biopsy proven non-alcoholic fatty liver disease. We compared characteristics of patients with and without diabetes and explored potential associations between classes of drugs as risk factors and advanced fibrosis among the diabetic patients with NAFLD.

Results: Presence of diabetes was an independent risk factor for advanced fibrosis. In diabetic patients, age (OR 1.09; 95%CI 1.04-1.15, p=0.000) and grade of ballooning (OR 5.59; 95%CI 2.69-11.61, p=0.000) had a positive relationship with advanced fibrosis. The use of insulin (OR 4.95; 95%CI 1.65-14.88, p=0.004) and sulfonylurea (OR 5.07; 95%CI 1.87-13.75, p=0.001) were positively associated while statin use (OR 0.31; 95%CI 0.12-0.78, p=0.013) was negatively associated with advanced fibrosis. Conclusion: Among non-alcoholic fatty liver disease patients with diabetes, the prevalence of advanced fibrosis was higher in patients treated with insulin and sulfonylurea, but lower in patients on statins. These findings provide support for a greater role of statin use in non-alcoholic fatty liver disease patients with diabetes while limiting the use of insulin and sulfonylurea.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords